Samsung Biologics Co Ltd Asset Resilience Ratio

Latest as of June 2026: 15.21%

Samsung Biologics Co Ltd asset resilience ratio. Samsung Biologics Co Ltd (207940) has an Asset Resilience Ratio of 15.21% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Samsung Biologics Co Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩1.92 Trillion

≈ $1.30 Billion USD Cash + Short-term Investments

Total Assets

₩12.65 Trillion

≈ $8.57 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Samsung Biologics Co Ltd (2016–2025)

Asset resilience ratio of Samsung Biologics Co Ltd from 2016 to 2025. This chart shows how Samsung Biologics Co Ltd's Asset Resilience Ratio has changed over time. Read Samsung Biologics Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Samsung Biologics Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Samsung Biologics Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.92 Trillion	15.21%
Total Liquid Assets	₩1.92 Trillion	15.21%

Asset Resilience Insights

Good Liquidity Position: Samsung Biologics Co Ltd maintains a healthy 15.21% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Samsung Biologics Co Ltd Industry Peers by Asset Resilience Ratio

Compare Samsung Biologics Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
Genmab A/S CO:GMAB	Biotechnology	23.50%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	Biotechnology	1.69%
Abivax SA American Depositary Shares NASDAQ:ABVX	Biotechnology	4.91%
Bachem Holding AG SW:BANB	Biotechnology	0.00%
Viking Therapeutics Inc NASDAQ:VKTX	Biotechnology	72.03%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%

Samsung Biologics Co Ltd Asset Resilience Ratio by Year (2016–2025)

Samsung Biologics Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Samsung Biologics Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.08%	₩1.34 Trillion ≈ $905.55 Million	₩11.06 Trillion ≈ $7.50 Billion	+6.66pp
2024-12-31	5.42%	₩940.07 Billion ≈ $637.07 Million	₩17.34 Trillion ≈ $11.75 Billion	-5.10pp
2023-12-31	10.52%	₩1.69 Trillion ≈ $1.14 Billion	₩16.05 Trillion ≈ $10.87 Billion	-3.37pp
2022-12-31	13.89%	₩2.30 Trillion ≈ $1.56 Billion	₩16.58 Trillion ≈ $11.24 Billion	-2.73pp
2021-12-31	16.61%	₩1.32 Trillion ≈ $897.27 Million	₩7.97 Trillion ≈ $5.40 Billion	+3.79pp
2020-12-31	12.82%	₩823.60 Billion ≈ $558.14 Million	₩6.42 Trillion ≈ $4.35 Billion	+3.27pp
2019-12-31	9.55%	₩564.82 Billion ≈ $382.77 Million	₩5.91 Trillion ≈ $4.01 Billion	-9.02pp
2018-12-31	18.58%	₩1.11 Trillion ≈ $752.88 Million	₩5.98 Trillion ≈ $4.05 Billion	+18.26pp
2017-12-31	0.31%	₩22.61 Billion ≈ $15.32 Million	₩7.18 Trillion ≈ $4.87 Billion	-12.78pp
2016-12-31	13.09%	₩986.29 Billion ≈ $668.39 Million	₩7.53 Trillion ≈ $5.11 Billion	--

pp = percentage points

About Samsung Biologics Co Ltd

KO:207940 Korea Biotechnology

Market Cap

$46.65 Billion

₩68.83 Trillion KRW

Market Cap Rank

#574 Global

#7 in Korea

Share Price

₩1487000.00

Change (1 day)

+8.86%

52-Week Range

₩1000000.00 - ₩1609000.00

All Time High

₩1609000.00